Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionGABA receptor binding

AKAP5 PLCL2 PLCL1

7.24e-0520823GO:0050811
DomainPH_12

PLCL2 PLCL1

2.76e-046812PF16457
Domain-

EFCAB6 PLCL2 MACF1 ACTN4 PLCL1 RYR2

9.51e-042618161.10.238.10
DomainEF-hand-dom_pair

EFCAB6 PLCL2 MACF1 ACTN4 PLCL1 RYR2

1.55e-03287816IPR011992
DomainPLipase_C_Pinositol-sp_Y

PLCL2 PLCL1

1.88e-0315812IPR001711
DomainEF-hand_like

PLCL2 PLCL1

1.88e-0315812PF09279
DomainMyosin_N

MYH7 MYH10

1.88e-0315812PF02736
DomainPIPLC_Y_DOMAIN

PLCL2 PLCL1

1.88e-0315812PS50008
DomainMyosin_N

MYH7 MYH10

1.88e-0315812IPR004009
DomainPI-PLC_fam

PLCL2 PLCL1

1.88e-0315812IPR001192
DomainPLC_EF-hand-like

PLCL2 PLCL1

1.88e-0315812IPR015359
DomainPI-PLC-Y

PLCL2 PLCL1

1.88e-0315812PF00387
DomainPLCYc

PLCL2 PLCL1

1.88e-0315812SM00149
DomainActin_CS

POTEF POTEI

2.14e-0316812IPR004001
DomainACTINS_2

POTEF POTEI

2.42e-0317812PS00432
DomainMyosin_tail_1

MYH7 MYH10

2.72e-0318812PF01576
DomainMyosin_tail

MYH7 MYH10

2.72e-0318812IPR002928
DomainPI-PLC-X

PLCL2 PLCL1

2.72e-0318812PF00388
DomainActin/actin-like_CS

POTEF POTEI

2.72e-0318812IPR020902
DomainPLCXc

PLCL2 PLCL1

2.72e-0318812SM00148
DomainPIPLC_X_DOMAIN

PLCL2 PLCL1

3.03e-0319812PS50007
DomainPLipase_C_PInositol-sp_X_dom

PLCL2 PLCL1

3.03e-0319812IPR000909
DomainMyosin-like_IQ_dom

MYH7 MYH10

3.03e-0319812IPR027401
Domain-

MYH7 MYH10

3.03e-03198124.10.270.10
DomainACTINS_ACT_LIKE

POTEF POTEI

3.03e-0319812PS01132
DomainActinin_actin-bd_CS

MACF1 ACTN4

4.43e-0323812IPR001589
DomainSpectrin

MACF1 ACTN4

4.43e-0323812PF00435
DomainACTININ_2

MACF1 ACTN4

4.43e-0323812PS00020
DomainACTININ_1

MACF1 ACTN4

4.43e-0323812PS00019
DomainANK

POTEB3 POTEF POTED POTEI POTEC

4.71e-03251815SM00248
DomainANK_REPEAT

POTEB3 POTEF POTED POTEI POTEC

4.87e-03253815PS50088
DomainANK_REP_REGION

POTEB3 POTEF POTED POTEI POTEC

4.95e-03254815PS50297
DomainEFh

EFCAB6 MACF1 ACTN4 RYR2

4.95e-03158814SM00054
Domain-

PLCL2 PLCL1

5.22e-03258123.20.20.190
DomainPLC-like_Pdiesterase_TIM-brl

PLCL2 PLCL1

5.22e-0325812IPR017946
DomainIQ

MYH7 MYH10 CEP97

5.26e-0381813SM00015
DomainAnkyrin_rpt

POTEB3 POTEF POTED POTEI POTEC

5.63e-03262815IPR002110
DomainSpectrin_repeat

MACF1 ACTN4

6.99e-0329812IPR002017
DomainIQ_motif_EF-hand-BS

MYH7 MYH10 CEP97

7.04e-0390813IPR000048
DomainIQ

MYH7 MYH10 CEP97

7.71e-0393813PS50096
DomainActin

POTEF POTEI

7.96e-0331812IPR004000
DomainActin

POTEF POTEI

7.96e-0331812PF00022
DomainACTIN

POTEF POTEI

7.96e-0331812SM00268
DomainSpectrin/alpha-actinin

MACF1 ACTN4

8.47e-0332812IPR018159
DomainPAS

NCOA1 PASD1

8.47e-0332812SM00091
DomainSPEC

MACF1 ACTN4

8.47e-0332812SM00150
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

TUBGCP6 AKAP5 ILF3 PSIP1 CENPC MACO1 KTN1 VPS35 OTUB1 PDCD11 MRPL19 MACF1 SLC30A1 OGA TRIM24 PREPL GOLGA3

6.82e-081487831733957083
Pubmed

Functional proteomics mapping of a human signaling pathway.

MYH10 RNF168 ZNF484 EXPH5 MACO1 VPS35 OTUB1 PLCL2 MACF1 MGA RYR2

1.66e-07591831115231748
Pubmed

POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer.

POTEB3 POTED POTEC

7.28e-07883312475935
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

CUL1 KDM3A USP6 MYH10 CTPS2 CELF1 PRIM1 KTN1 VPS35 OTUB1 OGA PREPL ARMC8

7.39e-071005831319615732
Pubmed

AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.

MYH10 ILF3 ACACA KTN1 VPS35 OTUB1 PDCD11 ACTN4 SLC30A1

2.40e-0648483931995728
Pubmed

TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.

MYH10 ILF3 KTN1 VPS35 ACTN4 TRIM24

4.64e-0617983636261009
Pubmed

Gene dosage affects the cardiac and brain phenotype in nonmuscle myosin II-B-depleted mice.

MYH7 MYH10

5.63e-06283210712438
Pubmed

Phospholipase C-related but catalytically inactive protein acts as a positive regulator of insulin signalling in adipocytes.

PLCL2 PLCL1

5.63e-06283234859819
Pubmed

Phospholipase C-related catalytically inactive protein regulates lipopolysaccharide-induced hypothalamic inflammation-mediated anorexia in mice.

PLCL2 PLCL1

5.63e-06283231589911
Pubmed

Phospholipase C-related inactive protein is involved in trafficking of gamma2 subunit-containing GABA(A) receptors to the cell surface.

PLCL2 PLCL1

5.63e-06283217301177
Pubmed

Inflammatory corpuscle AIM2 facilitates macrophage foam cell formation by inhibiting cholesterol efflux protein ABCA1.

ABCA1 AIM2

5.63e-06283238734775
Pubmed

Involvement of phospholipase C-related inactive protein in the mouse reproductive system through the regulation of gonadotropin levels.

PLCL2 PLCL1

5.63e-06283219553601
Pubmed

Genetic reduction of GABA(A) receptor gamma2 subunit expression potentiates the immobilizing action of isoflurane.

PLCL2 PLCL1

5.63e-06283220097266
Pubmed

Phospholipase C-related inactive protein is implicated in the constitutive internalization of GABAA receptors mediated by clathrin and AP2 adaptor complex.

PLCL2 PLCL1

5.63e-06283217254016
Pubmed

Phospholipase C-related but catalytically inactive protein is required for insulin-induced cell surface expression of gamma-aminobutyric acid type A receptors.

PLCL2 PLCL1

5.63e-06283219996098
Pubmed

Identification and characterization of a new phospholipase C-like protein, PLC-L(2).

PLCL2 PLCL1

5.63e-06283210581172
Pubmed

Transactivation of involucrin, a marker of differentiation in keratinocytes, by lens epithelium-derived growth factor (LEDGF).

IVL PSIP1

5.63e-06283212126624
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

ACACA MYPN MACF1 ACTN4 CEP97 GOLGA3

1.13e-0520983636779422
Pubmed

Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.

MYH7 CTPS2 VPS35 OTUB1 MACF1 SLC30A1 TRIM24

1.24e-0532283726514267
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

SETDB2 MYOF MYH7 ACACA TMOD1 OGA TRIM24 MGA GOLGA3 MAP3K19

1.26e-05754831035906200
Pubmed

Co-localization of CENP-C and CENP-H to discontinuous domains of CENP-A chromatin at human neocentromeres.

CENPC CENPH

1.69e-05383217651496
Pubmed

Phospholipase C-related but catalytically inactive protein modulates pain behavior in a neuropathic pain model in mice.

PLCL2 PLCL1

1.69e-05383223639135
Pubmed

Phospholipase C-related catalytically inactive protein, a novel microtubule-associated protein 1 light chain 3-binding protein, negatively regulates autophagosome formation.

PLCL2 PLCL1

1.69e-05383223399561
Pubmed

Phospholipase C-related catalytically inactive protein (PRIP) regulates lipolysis in adipose tissue by modulating the phosphorylation of hormone-sensitive lipase.

PLCL2 PLCL1

1.69e-05383224945349
Pubmed

Phospholipase C-related Catalytically Inactive Protein Is a New Modulator of Thermogenesis Promoted by β-Adrenergic Receptors in Brown Adipocytes.

PLCL2 PLCL1

1.69e-05383226706316
Pubmed

Involvement of PRIP, phospholipase C-related, but catalytically inactive protein, in bone formation.

PLCL2 PLCL1

1.69e-05383221757756
Pubmed

MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.

KDM3A GSE1 CENPC PDCD11 OGA TRIM24 MGA

1.73e-0533983730415952
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

NES MYH7 MYH10 ILF3 ACACA VPS35 OTUB1 MACF1 ACTN4 XRCC4 OGA PREPL

1.78e-051149831235446349
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

CUL1 NES MYH10 ILF3 ACACA CENPC KTN1 VPS35 PDCD11 MACF1 ACTN4 PRR14L MGA

1.85e-051353831329467282
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MYOF EXPH5 KTN1 TTC21B MACF1 MINAR1 MGA PDZRN4

2.40e-0549383815368895
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

MYH7 GSE1 KTN1 MYPN MACF1 ACTN4 MGA PREPL

2.54e-0549783823414517
Pubmed

Identification of pathogenic variants in genes related to channelopathy and cardiomyopathy in Korean sudden cardiac arrest survivors.

MYH7 RYR2

3.37e-05483228202948
Pubmed

Phospholipase C-related, but catalytically inactive protein (PRIP) up-regulates osteoclast differentiation via calcium-calcineurin-NFATc1 signaling.

PLCL2 PLCL1

3.37e-05483228341745
Pubmed

Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor.

NCOA1 TRIM24

3.37e-05483210935545
Pubmed

Changes in expression of nonmuscle myosin heavy chain isoforms during muscle and nonmuscle tissue development.

MYH7 MYH10

3.37e-0548328482409
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

MYH7 MYH10 AKAP5 ILF3 PSIP1 CENPC POTEF KTN1 VPS35 MACF1 ACTN4 POTEI RYR2

3.59e-051442831335575683
Pubmed

Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.

CUL1 MYH7 MYH10 POTEF PRIM1 KTN1 MACF1 ACTN4

4.44e-0553883828524877
Pubmed

Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells.

ABCA1 NCOA1

5.60e-05583214993927
Pubmed

Multiscale analysis of single and double maternal-zygotic Myh9 and Myh10 mutants during mouse preimplantation development.

MYH7 MYH10

5.60e-05583233871354
Pubmed

A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis.

NES XRCC4

5.60e-0558329875844
Pubmed

ASD-Associated De Novo Mutations in Five Actin Regulators Show Both Shared and Distinct Defects in Dendritic Spines and Inhibitory Synapses in Cultured Hippocampal Neurons.

MYH10 ACTN4

5.60e-05583230123108
Pubmed

Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1.

RNF168 OTUB1

5.60e-05583220725033
Pubmed

Pioneering function of Isl1 in the epigenetic control of cardiomyocyte cell fate.

MYH7 TMOD1 RYR2

7.43e-053483331024170
Pubmed

Hypertrophic Cardiomyopathy Overview

MYH7 MYPN RYR2

7.43e-053483320301725
Pubmed

CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.

MYOF MYH10 ILF3 KTN1 VPS35

7.75e-0518283531067453
Pubmed

GABA(A) receptor subunit alteration-dependent diazepam insensitivity in the cerebellum of phospholipase C-related inactive protein knockout mice.

PLCL2 PLCL1

8.39e-05683220412381
Pubmed

Activation of ATP-binding cassette transporter A1 transcription by chromatin remodeling complex.

ABCA1 NCOA1

8.39e-05683215774904
Pubmed

Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.

NCOA1 TRIM24

8.39e-0568329259327
Pubmed

TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT-GSK-3β-β-Catenin Signaling Pathway.

MYOF MYH7 MYH10 ILF3 ACTN4 POTEI

9.28e-0530583633194618
Pubmed

Identification of proximal SUMO-dependent interactors using SUMO-ID.

KDM3A ILF3 ACACA CELF1 TRIM24 MGA CEP97

9.50e-0544483734795231
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

NES MYH10 ILF3 KTN1 MACF1 PLCL1 MGA PREPL GOLGA3 ARMC8

9.89e-05963831028671696
Pubmed

Five POTE paralogs and their splice variants are expressed in human prostate and encode proteins of different lengths.

POTEB3 POTED

1.17e-04783215276201
Pubmed

Myosin regulatory light chains are required to maintain the stability of myosin II and cellular integrity.

MYH7 MYH10

1.17e-04783221126233
Pubmed

Retroviral DNA integration--mechanism and consequences.

PSIP1 XRCC4

1.17e-04783216291214
Pubmed

Modulation of GABA(A) receptor phosphorylation and membrane trafficking by phospholipase C-related inactive protein/protein phosphatase 1 and 2A signaling complex underlying brain-derived neurotrophic factor-dependent regulation of GABAergic inhibition.

PLCL2 PLCL1

1.17e-04783216754670
Pubmed

RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

MYH10 ILF3 POTEF PDCD11 GOLGA3

1.26e-0420283524639526
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

CUL1 MYOF MYH10 ILF3 ACACA PSIP1 KTN1 MACF1 ACTN4

1.32e-0480783930575818
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

CUL1 MYH10 ILF3 ACACA PSIP1 PRIM1 KTN1 VPS35 OTUB1 PDCD11 ACTN4 ARMC8

1.40e-041425831230948266
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

USP6 MXRA5 GSE1 KTN1 NCOA1 TRIM24 PREPL RYR2

1.45e-0463883831182584
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

CUL1 ILF3 RNF168 PSIP1 CENPC CENPH PRIM1 OTUB1 POLR2K XRCC4

1.51e-041014831032416067
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

EVI5 CUL1 MYOF MYH10 PSIP1 MACO1 KTN1 VPS35 OTUB1 TMOD1 PDCD11 ARMC8

1.55e-041440831230833792
Pubmed

Endogenous β-glucocerebrosidase activity in Abca12⁻/⁻epidermis elevates ceramide levels after topical lipid application but does not restore barrier function.

IVL ABCA1

1.56e-04883224293640
Pubmed

Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.

NCOA1 TRIM24

1.56e-0488329774463
Pubmed

Phospholipase C-related but catalytically inactive proteins regulate ovarian follicle development.

PLCL2 PLCL1

1.56e-04883228360101
Pubmed

A human MAP kinase interactome.

MYH10 KIAA1549L EXPH5 KTN1 MACF1 ACTN4 MGA

1.66e-0448683720936779
Pubmed

PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.

CUL1 MYOF MYH10 ILF3 PSIP1 CELF1

1.67e-0434083624332808
Pubmed

Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.

KDM3A ILF3 PDCD11 OGA

1.76e-0411683421282530
Pubmed

Knockout of Lmod2 results in shorter thin filaments followed by dilated cardiomyopathy and juvenile lethality.

MYH7 TMOD1

2.00e-04983226487682
Pubmed

MACF1 regulates the migration of pyramidal neurons via microtubule dynamics and GSK-3 signaling.

NES MACF1

2.00e-04983225224226
Pubmed

Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains.

POTED POTEI

2.00e-04983216364570
Pubmed

FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.

CUL1 PRIM1

2.00e-04983232576198
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

CUL1 MYH7 MYH10 GSE1 PSIP1 KTN1 TRIM24 MGA ARMC8

2.07e-0485783925609649
Pubmed

Interactome and Ubiquitinome Analyses Identify Functional Targets of Herpes Simplex Virus 1 Infected Cell Protein 0.

MYH10 ILF3 VPS35 ACTN4

2.28e-0412483435516420
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

ZNF484 MACO1 NCOA1 MAGEE1 SLC30A1

2.45e-0423383537704626
Pubmed

Comparative mapping in the beige-satin region of mouse chromosome 13.

INHBA RYR2

2.50e-04108329027500
Pubmed

Natural helix 9 mutants of PPARγ differently affect its transcriptional activity.

NCOA1 TRIM24

2.50e-041083230595551
Pubmed

Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology.

TMOD1 ACTN4

2.50e-041083220368620
Pubmed

Comprehensive analysis of the ICEN (Interphase Centromere Complex) components enriched in the CENP-A chromatin of human cells.

CENPC CENPH

2.50e-041083216716197
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

ILF3 KIAA1549L PSIP1 VPS35 MACF1

2.50e-0423483536243803
Pubmed

Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations.

MYOF POTEF MACF1 ACTN4 OGA

2.55e-0423583528378594
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

CUL1 KDM3A ILF3 GSE1 PSIP1 CELF1 OTUB1 NCOA1 ACTN4 TRIM24

2.95e-041103831034189442
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

IVL CENPH KTN1 OTUB1 PLCL2 TTC21B ACTN4 XRCC4 CEP97 CCDC144A ARMC8

3.00e-041321831127173435
Pubmed

The Tlx gene regulates the timing of neurogenesis in the cortex.

NES SALL3

3.05e-041183215385616
Pubmed

FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4.

CUL1 XRCC4

3.05e-041183226774286
Pubmed

Translational derepression of Elavl4 isoforms at their alternative 5' UTRs determines neuronal development.

NES CELF1

3.05e-041183232245946
Pubmed

New nomenclature for chromatin-modifying enzymes.

KDM3A SETDB2 NCOA1

3.49e-045783318022353
Pubmed

NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function.

MYH7 RYR2

3.66e-041283214633990
Pubmed

Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.

MYH7 MYH10

3.66e-04128328424456
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

MYH10 ILF3 ACACA GSE1 PSIP1 KTN1 MACF1 PRR14L OGA

3.89e-0493483933916271
Pubmed

Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.

MYOF ILF3 OTUB1 PDCD11

4.02e-0414483435681168
Pubmed

A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

CELF1 KTN1 ACTN4

4.07e-046083319075228
Pubmed

Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase.

ABCA1 ILF3 PDZRN4

4.07e-046083322889411
Pubmed

A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal components.

MYH7 MYH10 RNF168

4.07e-046083320682791
Pubmed

Biological, clinical and population relevance of 95 loci for blood lipids.

EVI5 ABCA1 MACO1 MACF1

4.23e-0414683420686565
Pubmed

CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1.

MYOF OTUB1 MRPL19

4.92e-046483336369321
Pubmed

Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.

CUL1 MYH7 ACACA MACF1

4.93e-0415283434299191
Pubmed

Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha.

NCOA1 PLCL1

5.03e-041483212039952
Pubmed

Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.

NCOA1 TRIM24

5.03e-041483211500849
Pubmed

The Nuclear SUMO-Targeted Ubiquitin Quality Control Network Regulates the Dynamics of Cytoplasmic Stress Granules.

ILF3 VPS35 ACTN4

5.14e-046583332521226
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

AKAP5 CTPS2 ACACA MACF1 SLC30A1 GOLGA3

5.23e-0442183636976175
InteractionPOTEC interactions

POTEB3 POTEF POTED POTEC

1.86e-0713834int:POTEC
InteractionPOTED interactions

POTEB3 POTED POTEC

2.69e-074833int:POTED
InteractionPOTEB3 interactions

POTEB3 POTEF MACO1 POTED POTEC

3.09e-0735835int:POTEB3
InteractionNPM1 interactions

CUL1 MYH7 MYH10 AKAP5 ILF3 ACACA PSIP1 CENPC KTN1 OTUB1 PDCD11 MRPL19 XRCC4 TRIM24 AIM2 GOLGA3 NPM2

6.49e-0612018317int:NPM1
InteractionTRIM52 interactions

MEIOC EXPH5 PRR14L TRIM24 MGA CEP97

1.84e-05133836int:TRIM52
InteractionGOLGA4 interactions

MYH10 ACACA VPS35 TMOD1 MACF1 GOLGA3 DIRAS3

4.10e-05226837int:GOLGA4
GeneFamilyAnkyrin repeat domain containing|POTE ankyrin domain containing

POTEF POTED POTEI POTEC

4.27e-0813524685
GeneFamilyAnkyrin repeat domain containing

POTEF POTED POTEI POTEC ANKRD18B

6.42e-04242525403
GeneFamilyMyosin heavy chains

MYH7 MYH10

8.32e-04155221098
GeneFamilyPhospholipases|C2 domain containing phospholipases

PLCL2 PLCL1

1.34e-0319522832
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

MYOF ABCA1 MYH10 MXRA5 MACF1 RYR2

1.86e-06197836fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH10 KIAA1549L CENPH PRIM1 MACF1

1.66e-05170835e20568c8f3f17d94de78229617eb2f7e4c5af2bc
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NES INHBA PLCL1 RYR2 PDZRN4

1.71e-051718354ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH10 KIAA1549L CENPH PRIM1 MACF1

1.96e-05176835d30241fb8119834d6e7b59efec3f92fc7a3d1247
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CUL1 MYH10 MEIOC PRIM1 MACF1

1.96e-05176835cb8fd56a4f935cdda19d7ab43382cdda7c307667
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ACACA MEIOC MACF1 MGA CEP97

2.07e-05178835c87945146b2734141f07b39d268e0d8086ee0364
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NES MYH10 PSIP1 CENPH PRIM1

2.13e-05179835ff678e2f33c914e3dd0f338ada25f506c3e3c980
ToppCellCOVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYH7 MYPN TMOD1 PLCL1 RYR2

2.25e-05181835719eb532453ab7cd7893726885bc75d74a10b21e
ToppCellLA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper

MYOF MYH10 MACF1 RYR2 PDZRN4

2.69e-0518883534e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCellfacs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN TMOD1 RYR2 PDZRN4

2.76e-05189835e758b264c0a47127e33e66c395cf5a3224c7305b
ToppCellfacs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN TMOD1 RYR2 PDZRN4

2.76e-05189835b98f60875b1a12b2ec9dc91889298ae57f98602f
ToppCellRV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

MYH7 MYPN ACTN4 PLCL1 RYR2

2.76e-051898350a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH10 BEND6 TMOD1 RYR2 PDZRN4

2.83e-051908352e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCellRV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper

MYH7 MYPN ACTN4 PLCL1 RYR2

2.83e-0519083593c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH10 BEND6 TMOD1 RYR2 PDZRN4

2.83e-051908350028f886c789ba238c031eae5d96acaed4af8c25
ToppCellLV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper

MYH7 MYPN PLCL2 PLCL1 RYR2

2.90e-0519183525f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCelldroplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN TMOD1 RYR2 PDZRN4

2.90e-05191835c172c9e17b893b290e4aa8af5e5e4cd3e4818372
ToppCelldroplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN TMOD1 RYR2 PDZRN4

2.90e-05191835715f5b449b8e075959c05a5b38389df319663164
ToppCellLV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper

MYH7 MYPN PLCL2 PLCL1 RYR2

2.98e-05192835ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NES MYH10 PSIP1 CENPH PRIM1

3.05e-05193835f25bdd10ef531b8d8441ea84573078b4b1b0f105
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYOF ABCA1 MYH10 MACF1 RYR2

3.53e-05199835a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYOF ABCA1 MYH10 MXRA5 RYR2

3.53e-051998358b86c69aaf60feff53aa782559cfece7342a23de
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

MYOF ABCA1 MYH10 MACF1 RYR2

3.62e-05200835a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NCOA1 CCDC168 AIM2 CCDC144A

1.44e-04142834f720f13b339589fa924a42e89393e5db0b26300b
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA1 TMOD1 PREPL GOLGA3

2.02e-04155834441fcb6d05364fc6f4973f0b973f1a80b573ce1f
ToppCellAdult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor

MYH10 DIRAS3 RYR2 PDZRN4

2.27e-04160834fd14dfeb7021a4b7299371854dc8fc1fd66c8dae
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CENPC TTC21B PLCL1 OGA

2.68e-0416783483969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCellPND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ACACA CENPH PLCL2 AIM2

2.74e-041688344c402a1613fcf0a6e4d9b9d5551812940e91ff32
ToppCellCOVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYH7 MYPN PLCL1 RYR2

2.87e-041708343f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PARP6 KDM3A SETDB2 OGA

3.00e-04172834965a9f62b73a7e3531c343121a7c507b7e1bfe05
ToppCellfacs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACACA TDP1 SAPCD1 PDZRN4

3.06e-041738348bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCellfacs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACACA TDP1 SAPCD1 PDZRN4

3.06e-041738343e3c61468e703330788a10d850ef41a85680f86d
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MYH10 PLCL1 RYR2 PDZRN4

3.06e-04173834cb6389536195443633adb06e5f1b7483530773d1
ToppCell390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells)

MXRA5 CCDC168 DIRAS3 RYR2

3.27e-04176834852d3da0907fe87c0ef23d75a63ce07619cf0c54
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KTN1 MACF1 GOLGA3 RYR2

3.27e-04176834749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

NES MYH10 MXRA5 BEND6

3.27e-04176834bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46
ToppCell390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells)

MXRA5 CCDC168 DIRAS3 RYR2

3.27e-04176834d2df1e435996c51213e88270af9f928e9e09a6f5
ToppCell343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells)

MYH10 MXRA5 DIRAS3 RYR2

3.34e-04177834e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87
ToppCell343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells)

MYH10 MXRA5 DIRAS3 RYR2

3.34e-0417783443ba6f12c2fb32698a420bf799d46ac1b558f146
ToppCellcellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MYPN TMOD1 PLCL1 RYR2

3.41e-041788348ec2a25dda96c9cc9c2904b6cb18f75a293f4969
ToppCellcellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MYPN TMOD1 PLCL1 RYR2

3.41e-041788346c91331196696e0cf239d105f458e3230659fa38
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

AKAP5 INHBA TMOD1 CCDC144A

3.48e-041798349ba8693fba2175bca9ff9735cc04e657abeb9084
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

MYH10 TMOD1 RYR2 PDZRN4

3.56e-04180834d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCellCOVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type

MYH7 MYPN XRCC4 RYR2

3.71e-04182834287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCellCOVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYPN TMOD1 PLCL1 RYR2

3.79e-041838342902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

EXPH5 TMOD1 ANKRD18B CCDC144A

3.79e-041838341645d4a55cd8c22d6eb47fc5c6b1e576c454f111
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

ILF3 VPS35 TDP1 MGA

3.87e-041848349cbfb9f09476b4d09eb8f92c6f21e449dabcfa98
ToppCellLV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper

MYH7 MYPN PLCL1 RYR2

3.87e-04184834ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCellCOVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYH7 MYPN TMOD1 RYR2

3.87e-04184834e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCellLPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYOF TMOD1 PLCL1 RYR2

3.87e-04184834327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCellCOVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYH7 MYPN PLCL1 RYR2

3.95e-04185834549eeb521c3985bff396ea0f202db21822efa51f
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES EXPH5 TMOD1 ACTN4

3.95e-041858349197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES EXPH5 TMOD1 ACTN4

3.95e-04185834ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCellLV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

MYH7 MYPN PLCL1 RYR2

3.95e-041858346baccb26f999145e51b91d94315bf8d4655bef31
ToppCellLPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MACO1 PLCL2 TMOD1 SLC30A1

4.03e-04186834e5014443e9d6e25943308483e20d48b776ae5373
ToppCellfacs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN RYR2 PDZRN4

4.03e-04186834337f768cc43db2db96ba6495b076006b1a5b0331
ToppCellfacs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN RYR2 PDZRN4

4.03e-04186834e378c82ef6d6cb24751515aa499a01372b3e7ccf
ToppCelldroplet-Marrow-nan-21m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH10 PSIP1 CENPH TMOD1

4.03e-041868346e6998f5ccb1b2628048a21e8d3053e020569aba
ToppCellLPS_only-Hematopoietic_Meg-Ery-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MACO1 PLCL2 TMOD1 SLC30A1

4.03e-04186834affc246a1091e44dc85a5e237c778a7541d5a2b4
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NES PLCL1 RYR2 PDZRN4

4.03e-041868344780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCellLPS_only-Hematopoietic_Meg-Ery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MACO1 PLCL2 TMOD1 SLC30A1

4.03e-0418683440d1e15402fdfb3b5ae850a2070cd4b68fda3159
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NES PLCL1 RYR2 PDZRN4

4.03e-04186834a95744b8649096bd7cfc3591a02841fa411085b3
ToppCellCOVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations)

MYH10 TMOD1 RYR2 PDZRN4

4.11e-04187834464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCellfacs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN TMOD1 RYR2

4.19e-0418883490dc0e15798d0b984518ad58c7e416e30aff687a
ToppCellFibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4)

MYH10 PSIP1 CENPH PRIM1

4.19e-04188834be3db9768364568f44e32ae6b3bf99e49b0978bb
ToppCellfacs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN TMOD1 RYR2

4.19e-04188834f63dfd076ced81013918363282ae25cbbd8948ae
ToppCellfacs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN TMOD1 RYR2

4.19e-041888340554d542149cef654ff1e5e32dfbffd8990b52bd
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA1 SALL3 VPS35 MACF1

4.28e-041898346dd4ec5ce4beb856f0d2d1654e3c4676d1d63736
ToppCellRV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

MYH7 PLCL2 PLCL1 RYR2

4.28e-041898345e80c47f63980904c4c1ff02c201b67b456a0974
ToppCellCOVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type

SALL3 KIAA1549L INHBA TMOD1

4.28e-041898347346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCellfacs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN TMOD1 RYR2

4.28e-04189834a08b2d0fa35ffa510050ecffdc68e1b79bbe1632
ToppCelldroplet-Marrow-BM_(NON-STC)-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH10 PSIP1 CENPH PRIM1

4.28e-0418983416dfc37d8d390ed7f927bc844c47c9c5a89a0928
ToppCelldroplet-Marrow-BM_(NON-STC)-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH10 PSIP1 CENPH PRIM1

4.28e-041898343ade3fa9369e85304b20d7233b581f18ad5ecc89
ToppCellLA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

MYOF MYH10 MACF1 PDZRN4

4.28e-041898346b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA1 SALL3 VPS35 MACF1

4.28e-041898343ae479ec7e00c57127cbe51a398329b10ca9848c
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA1 SALL3 VPS35 MACF1

4.28e-04189834875df61ee48baa5142ba4d2427bdec1c53e5a828
ToppCellfacs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN TMOD1 RYR2

4.28e-04189834efa913d9c16fc32166b484d92b6449e8a0c59e03
ToppCellfacs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA1 SALL3 VPS35 MACF1

4.28e-0418983497ef5215d841ff366a3e3682cd9bd04100cbfde0
ToppCellLV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

MYH7 PLCL2 PLCL1 RYR2

4.36e-04190834de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCellCOVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYH7 MYPN TMOD1 RYR2

4.36e-04190834918ad5037881212008f9f69d5df5da91fd01422c
ToppCellControl-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class

MYOF GSE1 AIM2 PDZRN4

4.36e-041908344e30155203b4a8c5e496fcbe9348b67b98ebc625
ToppCellPCW_13-14|World / Celltypes from embryonic and fetal-stage human lung

GSE1 NCOA1 MACF1 OGA

4.36e-0419083462a3ec1ae0829602b0569cc051210551644f1d46
ToppCellRV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper

MYH7 PLCL2 PLCL1 RYR2

4.36e-04190834fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

MYOF MXRA5 INHBA RYR2

4.45e-04191834156b467187331ac6ca390d6ca861d9670bb7b956
ToppCelldroplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN TMOD1 RYR2

4.45e-0419183497fb4232417a39801e87725755fd16a57c250209
ToppCelldroplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH7 MYPN TMOD1 RYR2

4.45e-0419183464070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCelldroplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYPN TMOD1 RYR2 PDZRN4

4.54e-041928340bf99e029a06151092db1e8a0dcb45f4e688e771
ToppCelldroplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYPN TMOD1 RYR2 PDZRN4

4.54e-04192834d766221acfce30cbf2c60b3ae40f6744968b952c
ToppCellCOVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

MYH7 MYPN PLCL1 RYR2

4.63e-04193834dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

MYOF MXRA5 INHBA PLCL1

4.63e-04193834cd45118ced91b10baed3b1068d4673ec99824b86
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PARP6 MYH10 MINAR1 NPM2

4.63e-04193834088c8b1e968f5356502347eaabdc6b1b1d4befd0
ToppCellE18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NES RNF168 CENPH PRIM1

4.72e-04194834ae6d5cf4c825b29e677296df2c0985431c83b82e
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

GSE1 MACF1 ACTN4 MINAR1

4.72e-0419483424837a27b0041fe8c348225fa8b09b127d743603
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH10 PSIP1 CENPH PRIM1

4.72e-04194834af4bbb2deb5a3913eb58990690fc3c62fbc3708c
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells)

EVI5 KDM3A ABCA1 PDCD11

4.72e-0419483488db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYH10 TMOD1 RYR2 PDZRN4

4.72e-041948345c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells)

EVI5 KDM3A ABCA1 PDCD11

4.72e-04194834a71728202493d4858342ea2756ea281cd0d99a3a
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYH10 TMOD1 RYR2 PDZRN4

4.72e-04194834ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCellCOVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type

MYH7 MYPN PLCL1 RYR2

4.81e-04195834f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCellCOVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type

MYH7 MYPN PLCL1 RYR2

4.81e-0419583475fc81bddb246dca3b437fb60827b1d4fe416405
Diseasefornix volume measurement

EVI5 PLCL1

1.44e-047782EFO_0803381
DiseaseHypertrophic Cardiomyopathy

MYH7 MYPN RYR2

4.69e-0457783C0007194
Diseaserestrictive cardiomyopathy (implicated_via_orthology)

MYH7 MYPN

5.28e-0413782DOID:397 (implicated_via_orthology)
Diseaseeating disorder, bipolar disorder

AIM2 RYR2

6.15e-0414782EFO_0005203, MONDO_0004985
Diseaseresponse to methotrexate, neurotoxicity

MACF1 PLCL1

1.15e-0319782EFO_0011057, GO_0031427
Diseasebeverage consumption measurement

NCOA1 PLCL1 RYR2

1.40e-0383783EFO_0010088
DiseaseHyalinosis, Segmental Glomerular

MYH10 ACTN4

2.49e-0328782C0086432

Protein segments in the cluster

PeptideGeneStartEntry
KRVQMEQPDAVPAQK

TTC21B

866

Q7Z4L5
PIQMKPADSEKNNAV

CELF1

91

Q92879
VKPEQKQMVAQQESI

AIM2

131

O14862
PDEMNNSPNFEEKKK

GSE1

851

Q14687
TEEQMAQQPPKGQAQ

GRAMD4

136

Q6IC98
PPSQEVNDAIKQMKK

ABCA1

1546

O95477
PQKTIQEMQQKLEDF

ACTN4

321

O43707
NDNQETAAMKPENLK

ANKRD18B

266

A2A2Z9
AKMQLDNPSKVQQAE

ACACA

816

Q13085
DKAVKPAMNQNEVQE

BEND6

221

Q5SZJ8
DVPNSQPEMVEAVKK

INHBA

46

P08476
NEAMQPTANEVEQPK

PDZRN4

516

Q6ZMN7
VKEDQVMQQNPPKFD

MYH7

71

P12883
SQPEKMSQEPEINKD

POTEF

396

A5A3E0
KPQDPMEQNVAELLQ

MAGEE1

486

Q9HCI5
KVMEQQSNLQPEAKE

MGA

2146

Q8IWI9
LPPEQQMLQKQEKEA

MACO1

201

Q8N5G2
PMKENQPNEVPEDNL

CSNKA2IP

536

A0A1B0GTH6
KDPPKKNAMNELQDE

EVI5

551

O60447
NQGAMNPLEKEIQEP

NES

856

P48681
KMDQTNKAGEIPQPV

EXPH5

716

Q8NEV8
VSEQPNKDVVEQMEK

KTN1

721

Q86UP2
QDETQQLQPDMSKLP

TUBGCP6

51

Q96RT7
PQNVMAQQKVTKEEA

KIAA1549L

1311

Q6ZVL6
LSKQPVGNQEMENLK

GOLGA3

1276

Q08378
KEQVDPLQMKLQQVN

MACF1

5281

Q9UPN3
GQMLQKEPEEEQQKQ

PASD1

551

Q8IV76
KVSENSQPEKMSQEP

POTEB3

391

A0JP26
SQPEKMSQEPEINKD

POTEB3

396

A0JP26
NNQSDLEKEMQKMNP

PRIM1

61

P49642
MAAEEPQQQKQEPLG

OTUB1

1

Q96FW1
PDPQKVLQGVIDMKN

ARMC8

31

Q8IUR7
NVNKENKEKQPTMPI

KDM3A

831

Q9Y4C1
EKTPEQIMQEKQIEA

CENPH

66

Q9H3R5
TKPQQLQEEMKELQQ

EFCAB6

936

Q5THR3
KNEDNIMTAQNVPLK

CENPC

641

Q03188
KQSDIKKPENTQPEN

CEP97

511

Q8IW35
RVNINVPMKTEQKQE

CUL1

681

Q13616
QEDPPLMVKKNSVVQ

C3orf20

766

Q8ND61
QKKEEKAEPPQAMNA

ILF3

391

Q12906
ENKQPQKTSQEPEMA

CCDC144B

241

Q3MJ40
KQQKPLEGEMQPAIN

AKAP5

96

P24588
APQNIEEQDIVMKKQ

CCDC168

5821

Q8NDH2
DPQPFAVDKQQMQKL

CCDC168

6206

Q8NDH2
ENKQPQKTSQEPEMA

CCDC144A

241

A2RUR9
LQEPEKKSQMPNTTE

DIRAS3

206

O95661
QLVENIDKKMTDPNQ

SALL3

666

Q9BXA9
PMPEVQEKFQEQKAK

RYR2

4411

Q92736
PPANQEDKKMQPVTI

NPM2

66

Q86SE8
SPPQEMSQEDLKEKN

MAP3K19

91

Q56UN5
PIPGQQDKDNFQETM

MYH10

316

P35580
QNQPKADKDESTMIN

PRR14L

1431

Q5THK1
ANINTQDPKIQKEIM

PARP6

606

Q2NL67
KVSENSQPEKMSQEP

POTEC

391

B2RU33
SQPEKMSQEPEINKD

POTEC

396

B2RU33
DQKMQQPEKVSVQID

MINAR1

631

Q9UPX6
KVSENSQPEKMSQEP

POTED

391

Q86YR6
SQPEKMSQEPEINKD

POTED

396

Q86YR6
PANQKKMEETIPDQQ

MEIOC

376

A2RUB1
PMQTDEQTNKEQFVP

OGA

526

O60502
EKKEQMDPCNTNPTP

NCOA1

776

Q15788
MGKENMEQPNNVPVK

PLCL2

596

Q9UPR0
SQPEKMSQEPEINKD

POTEI

396

P0CG38
RQQKGVTQPKEEMAQ

SAPCD1

121

Q5SSQ6
LDQQEKQPELPEQQM

IVL

296

P07476
VPPITVNAKMNKDVN

CLCA4

591

Q14CN2
QMETEQQNKDEGKKP

PSIP1

321

O75475
DVNMKPVVQEPNQKV

MRPL19

201

P49406
EMPSKEKQQPQKPQA

PDCD11

1451

Q14690
PEQKKVAQDMTQPLS

PLCL1

391

Q15111
LQPEMPQKQAEKVVI

TDP1

96

Q9NUW8
MNQAKVPVDGNKEEP

CTPS2

126

Q9NRF8
EDKESQPQMPKQNPV

TRIM24

426

O15164
SDPMPVTQKEQENKS

SETDB2

81

Q96T68
KIDNQSQPLGNKVEM

TMOD1

286

P28289
NKKNDEMQEVPNRVL

SPANXN3

21

Q5MJ09
MPTTQQSPQDEQEKL

VPS35

1

Q96QK1
GTEPKMAPQENQLQE

XRCC4

281

Q13426
IDQKMPDIEPNSENN

ZNF654

956

Q8IZM8
QPVKQENEKPLPENM

PREPL

76

Q4J6C6
MDTQKDVQPPKQQPM

POLR2K

1

P53803
LQLQKEVDKEQMVPN

RNF168

451

Q8IYW5
KPQLSMPQKSDNGEV

ZNF484

816

Q5JVG2
MEDPNPEENMKQQDS

ZNF576

1

Q9H609
VVIEIKNMPNKQPES

SLC30A1

491

Q9Y6M5
DQQEHVVPKSQPKTM

USP6

236

P35125
NTPKQLEMEKNAEPT

MXRA5

1211

Q9NR99
QNPPKVIMELFDNDQ

MYOF

1206

Q9NZM1
NKEEMNRIQKPNEVS

MYPN

371

Q86TC9